Clinical Trial Update: Radiopaque Hydrogel Spacer in Patients Undergoing Radiotherapy for Pancreatic Cancer [NA]

View source ↗

Summary

Clinical trial update on radiopaque hydrogel spacer used during radiotherapy for pancreatic cancer; study completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• radiopaque hydrogel spacer

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Pancreatic Cancer | NA | Status: COMPLETED | Results posted: 2023-02-27